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The gut of the human neonate is colo-nized rapidly after birth from an
early sparse and highly distinct micro-
biota to a more adult-like and convergent
state, within 1 to 3 years. The progres-
sion of colonizing bacterial species is
non-random. During the first months of
life several shifts commonly occur in the
species prevalent in our guts. Although
the sequential progression of these spe-
cies is remarkably consistent across indi-
viduals and geographies, there is inter-
individual variation in the rate of pro-
gression. Our study and others suggest
that the rate is influenced by environ-
mental factors, and influences our future
health. In this article, we review our
recent contribution to cataloging the
developing infant gut microbiota along-
side other important recent studies. We
suggest testable hypotheses that arise
from this synthesis.
The fetus is almost sterile during the
gestational period,1 and birth starts a pro-
cess of colonization by microorganisms.
How the gut is colonized is of interest for
at least three reasons. Firstly, the make-up
of the gut microbiota has been causally
linked with metabolic health and dis-
ease.2-4 Secondly, microbiota may be a
mechanism for developmental program-
ming;5 while the infant gut microbial
composition does not necessarily predict
the make-up of the adult gut microbiota,6
it does affect the infant’s developing
immune system and metabolism.7,8
Finally, the gut microbiota can be sam-
pled non-invasively, albeit with some loss
of accuracy and complexity, by studying
fecal matter.9
Yatsunenko et al,10 among others
found that the fecal microbiome varies
strongly but predictably with age over the
first few years of life. They also found that
this progression with age was essentially
consistent across Venezuela, Malawi and
USA, although there were some strong
differences in microbiota content across
geographies. In a fascinating study of pre-
mature infants in a neonatal intensive care
ward designed to minimize sources of bac-
terial exposure, La Rosa et al,11 found
that the progression of microbial species
found in fecal samples followed a similar
pattern to that described before and
included discrete stages where particular
phyla dominated. They found that extrin-
sic factors “influenced the pace, but not
the sequence, of progression.” These stud-
ies might suggest that intrinsic factors
such as gut maturity are driving the pro-
gression. External environmental factors
such as delivery mode, antibiotic exposure
and feeding style strongly affect the infant
fecal microbiota,12 but maybe only the
rate of its establishment.
In our recent publication,13 we found
that 75 newborn babies from the Singa-
porean GUSTO birth cohort went
through a progression of gut microbiota
acquisition, similar to the studies
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previously mentioned and others. We
used 16S rRNA pyrosequencing of stool
samples collected at ages 3 days, 3 weeks,
3 months and 6 months and classified the
fecal microbiota by non-supervised clus-
tering; over this period the majority of
infants progressed from a “cluster-2” fecal
microbial profile (high in Enterobacteria-
ceae and Klebsiella) to a “cluster-3” fecal
microbial profile (high in Bifidobacteria
and Collinsella). In our study, 88% of the
babies reached a cluster-3 classified profile
by age 6 months, but there was substantial
inter-individual variation in the rate at
which it was reached. At day 3 26% of the
neonates already had fecal microbiota
which classified as cluster-3, while 1% of
the babies only reached cluster-3 by
month 6; the remaining reached there at
week 3 (35%) or month 3 (26%). Most
studies of infants that studied inter-indi-
vidual variation have reported differences
between individuals of the same age.
However, we postulated that the rate of
microbiota acquisition is an important
source of inter-individual variation.
Subsequent to the publication of our
article, B€ackhed et al,14 published a com-
prehensive study of the fecal microbiota of
98 Swedish infants sampled at birth,
month 4 and month 12 along with fecal
samples from their mothers. Crucially,
they employed metagenomic sequencing,
a much more quantitative and compre-
hensive methodology, which allows iden-
tification of bacterial species and genes,
and so can describe functional capacity.
Both B€ackhed et al,14 and our own
study,13 found that fecal samples were
more similar within time-points than
within individuals.
B€ackhed et al,14 also described a shift in
the fecal microbiota over time. Their Fig-
ure 1 showed microbiota within a week of
birth very similar to our cluster 2 micro-
biota, high in Enterobacteriaceae species
such as Escherichia/Shigella and in Strep-
tococcus. Species characteristic of cluster 3
in our study,13 such as Bifidobacterium
and Collinsella, peaked in relative abun-
dance at month 4 in B€ackhed’s data. The
Swedish data showed a further large transi-
tion between the month 4 and month 12
samples. Our data did not extend past
month 6 and so did not include this shift
to the Bacteroidetes and Firmicutes species
documented by B€ackhed et al.
Figure 1a presents a simplified sche-
matic of what is known about the progres-
sion of species in the infant fecal
microbiota over time. The Bacilli class
dominated stage A is found chiefly in pre-
mature infants, as documented by La Rosa
et al.,11 and rarely in other infants. Stage B
dominated by Proteobacteria and termed
Cluster 2 in our study, seems to exist from
birth or soon after in term infants; B€ackhed
et al.,14 also observed this profile in sam-
ples at birth, La Rosa et al.,11 observed it
at post-conceptional ages 32–34 weeks,
and many other studies have also reported
a similar profile.12 Progression from Stage
B to Stage C (Actinobacteria dominated,
called Cluster 3 in our study) occurred
between birth and month 6 in our study.13
The species characteristic of Cluster 3, e.g.
Bifidobacterium, peaked in relative abun-
dance in the samples at month 4 in
B€ackhed et al.14 It was also the most fre-
quent profile observed in fecal samples of
24 Canadian infants at 4 months of age.15
Interestingly it was absent from the study
Figure 1. (a) schematic diagram representing a simpliﬁed view of the progression of the infant fecal
microbiota across the ﬁrst year of life, incorporating Stages (A–D). (b–e) present putative modiﬁca-
tions to the progression caused by intrinsic and extrinsic factors.
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of premature infants by La Rosa et al.11
Another dramatic shift from Actinobacteria
to Firmicutes and Bacteroidetes occurs
between month 4 and years 1-3 in term
infants,14,16 and perhaps earlier in prema-
ture infants.11 Stage D represents a more
adult-like microbiota.10,12,14
Our thesis is that population shifts in
the core microbiota are developmental-
stage specific. Our study and others suggest
that extrinsic factors primarily contribute
to inter-individual diversity in rate of pro-
gression. Furthermore, the rate of progres-
sion influences health later in life.
In both our study,13 and B€ackhed
et al.14 there was a profound effect of
delivery mode on the infant gut micro-
biota, which was most marked at early
time-points and decreased at later ages. In
B€ackhed et al (2015) the infants born by
Caesarean section had much sparser early
fecal microbiota, which tended to contain
species usually found on adult skin, while
the fecal microbiota of the vaginally deliv-
ered infants closely resembled the fecal
microbiota of their mothers. Even at the
12-month time-point the Bacteroidetes
phylum was less abundant in infants born
by Cesarean section. We also found that
Bacteroidetes was absent from infants
born at Caesarean section at all time-
points, although we note that it was vari-
ably present in the vaginally born infants.
These findings echo those of Jakobsson
et al.17 B€ackhed et al.,14 found strong evi-
dence for vertical transmission of Bacter-
oides fragilis and Bacteroides thetiaot-
aomicron among other species in vaginally
delivered infants.
So, delivery mode affects the infant
microbiota in cross-sectional comparisons,
i.e. when comparing infants at the same
age. However, this apparent difference in
microbiota composition could be explained
by differences in rate of progression
through the same stages. In our study those
infants who were vaginally delivered tended
to reach the Actinobacteria dominated
Cluster-3/ Stage C earlier. It is difficult to
determine if the rate of progression from
Stage B to Stage C is affected by delivery
mode in the data of B€ackhed et al.,14 but
it is possible to observe in their Figure 1
that many of the vaginally delivered babies
already had high levels of Bifidobacterium
and Collinsella as neonates.
B€ackhed et al.14 used the random for-
est approach, which was developed by
Subramanian et al.18 to describe delay in
the normal development of the gut micro-
biota in malnourished children. They
found that babies born by Cesarean sec-
tion (or fed formula) had fecal microbiota
that were characterized as older than their
chronological age at 4 months. At first
appearance this is in contrast to our con-
clusion,13 which proposed babies born by
Cesarean tended to reach Cluster 3 (Stage
C) later than vaginally delivered infants.
However, Cluster 3 represents a month 6
pre-weaning microbiota and not the Stage
D weaned microbiota that represents
maturity (and on which the random for-
ests algorithm was trained) in the B€ackhed
et al. data. Perhaps the Caesarean deliv-
ered infants spend a relatively compressed
time at Stage C but instead convert rela-
tively rapidly from Stage B to Stage D
(Fig. 1c).
Premature infants have repeatedly been
shown to have a markedly different gut
microbiota to term infants,19 with a bacilli
dominated phase,11 delayed or missed
acquisition of Bifidobacteria,11,20,21 and
earlier acquisition of Firmicutes,11
(Fig. 1d). Our study was unusual in show-
ing a difference in the acquisition of gut
microbiota across the normal range of ges-
tational ages. All the infants in our study
were born at term but those born at 38
weeks tended to reach Cluster 3 later than
those born at 39 or more weeks’ gestation.
Indeed, the median gestation for those
who reached Cluster 3 at day 3 was 39.2
weeks as compared to 38.5 weeks for those
who reached Cluster 3 at month 6. Over-
all, a difference in gestational duration of
about a week was associated with a lag in
gut microbiota acquisition measured in
months.
Others have suggested that host physi-
ology drives the differences in gut micro-
biota between premature and term
infants.16,22 In particular a defective
mucin barrier especially MUC2 may lead
to unbalanced microbiota.23,24 Perhaps
subtle immaturity of the gut in the early
term infants is enough to delay microbiota
acquisition. However cause and effect are
difficult to unpick: Athalye-Jape et al.
showed that administering probiotics can
speed up gut maturation in premature
infants,25 suggesting that the gut micro-
biome can influence physiology and vice-
versa. Administering IGF1 in utero may
speed development of the guts of prema-
ture infants,26 and it would be telling if
this also affected the gut microbiota.
The most dramatic shift in the
B€ackhed et al.14 data is between the
months 4 and 12, Stage C to Stage D.
The month 12 microbiota of the infants is
more similar to the adult profiles of their
mothers than to either the birth or month
4 profiles and led the authors to speculate
that infants could reach a “steady-state”
profile at about one year old, similar but a
bit earlier to the 1-3 y time-point pro-
posed by Yatsunenko et al.10 The intro-
duction of solid food (weaning) usually
within 4 and 12 months of life has been
previously implicated in this shift,16 but
B€ackhed et al.14 emphasize the role of
breast-feeding. Infants that were still
breastfed at age 12 months tended to have
fecal microbiota containing the Actino-
bacterial species seen at 4 months of age
and characteristic of Stage C. Also, as
mentioned above the machine learning
approach employed by B€ackhed et al.14
determined that formula fed infants
tended to have a profile that was character-
ized as “older” than that of breast fed
infants at the birth and 4-month time-
points. Therefore, breastfeeding seems to
delay the progression to Stage D, even
after introduction of solid food.
In summary, the timing of the transi-
tion between Stages B and C is affected by
delivery mode and gestational duration.
Similarly, the timing of the transition
between Stage C and D seems to also be
influenced by mode of delivery and more
importantly the intake of breast milk and
solid food. An obvious following question
is: does the timing matter?
Cox et al.27 showed in mice that dis-
ruption of the early microbiota (by a
low dose of penicillin limited to gesta-
tion and infancy) could enhance the
effect of diet in inducing obesity in
adulthood. In humans too, early treat-
ment with antibiotics is associated with
later adiposity.28,29 Taking antibiotics
delays the progression of the gut micro-
biota,30,31 (Fig. 1e). Antibiotic usage at
the end of gestation and during early
infancy correlates with increased body
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size in childhood,32 and risk of being
overweight.33
Babies born prematurely show a lag in
the proper colonization of the gut,31 and
less time at Bifidobacteria dominated
Stage C;20 they are also at higher risk for
obesity later in life.34,35 Similarly individ-
uals born by Caesarean section have a
slower rate of progression to Stage C,13,14
and are also at higher risk for obesity.36,37
However, longer duration of breastfeeding
is associated with longer at Stage C,14 and
is protective of obesity.36,38 In our
study,13 those infants which reached Clus-
ter 3 (aka Stage C) later were more likely
to be of median adiposity at 18 months
old, while those who got there later were
more likely to be significantly under-
weight at age 18 months. Those who had
high levels of the Firmicutes genera Strep-
tococcus at the month 6 time-point (char-
acteristic of Stage D and so presumably
these infants paused at Stage C for a
shorter time), had a higher than average
adiposity gain between birth and
18 months of age. Previous cross-sectional
studies have found lower Bifidobacterium
levels in fecal samples from children youn-
ger than 6 months correlates with future
obesity at 7 and 10 y of age, compared to
normal weight controls.39,40
Many researchers are asking if chang-
ing the early microbiota by pre- or probi-
otics, could affect later phenotype and
perhaps prevent obesity.41 In agreement
with the hypothesis presented here, others
have suggested that infants born at earlier
gestations,42 or by Caesarean section,43
would benefit from intervention to get
them to Stage C faster and keep them
there longer.44,45
Our present understanding of the
progression of the infant gut microbiota
is crude. Figure 1 represents a testable
hypothesis but is oversimplified and
most likely incorrect in detail. More
studies sampling infants at more fre-
quent time-points are needed to build a
better and more complete picture.
Employing the type of metagenomic
approach exemplified by B€ackhed
et al,14 is not only more quantitative
but starts to provide insights into the
functional capacity of the microbiota.
Even more informative would be meta-
transcriptomic approaches that provide
information of which genes are
expressed in the microbiome.
The following is a short-listing of some
of the most pressing questions:
(1)There are almost certainly more stages
we have yet been able to capture - what
are they?
(2)Are the stages discrete or are they more
gradual than our sparse data suggests at
present?
(3)Do all infants progress through all
stages or do some infants miss some
stages completely?
(4)What are the intrinsic and extrinsic
factors that influence speed of progres-
sion at different points? How do they
interact?
(5) Several studies have documented the
influence of the maternal microbiome
and vertical transmission,46 is this how
factors such as delivery mode affect
rate of progression?
(6) Is it beneficial to progress through
some stages fast and others more
slowly? For instance, is it beneficial for
future metabolic health to progress
through Stage C slowly?
(7) It is interesting to note that the recov-
ery of the childhood and adult gut
microbiota after diarrhea has also been
observed to be orderly and reproduc-
ible.47,48 If as suggested by the authors,
intrinsic factors govern the progres-
sion: are there similarities within indi-
viduals between the original process of
colonization and the re-colonization
that occurs after diarrhea?
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